Yildirim, F. Et Al. 2022. Thrombocytopenic patients with hematological malignancy who underwent fiberoptic bronchoscopy are they really under a significant hemorrhagic risk?. EGYPTIAN JOURNAL OF BRONCHOLOGY , vol.16, no.1 .

Yildirim, F., ÖZKALEMKAŞ, F., & URSAVAŞ, A., (2022). Thrombocytopenic patients with hematological malignancy who underwent fiberoptic bronchoscopy are they really under a significant hemorrhagic risk?. EGYPTIAN JOURNAL OF BRONCHOLOGY , vol.16, no.1.

Yildirim, Fatih, FAHİR ÖZKALEMKAŞ, And AHMET URSAVAŞ. "Thrombocytopenic patients with hematological malignancy who underwent fiberoptic bronchoscopy are they really under a significant hemorrhagic risk?," EGYPTIAN JOURNAL OF BRONCHOLOGY , vol.16, no.1, 2022

Yildirim, Fatih Et Al. "Thrombocytopenic patients with hematological malignancy who underwent fiberoptic bronchoscopy are they really under a significant hemorrhagic risk?." EGYPTIAN JOURNAL OF BRONCHOLOGY , vol.16, no.1, 2022

Yildirim, F. ÖZKALEMKAŞ, F. And URSAVAŞ, A. (2022) . "Thrombocytopenic patients with hematological malignancy who underwent fiberoptic bronchoscopy are they really under a significant hemorrhagic risk?." EGYPTIAN JOURNAL OF BRONCHOLOGY , vol.16, no.1.

@article{article, author={Fatih Yildirim Et Al. }, title={Thrombocytopenic patients with hematological malignancy who underwent fiberoptic bronchoscopy are they really under a significant hemorrhagic risk?}, journal={EGYPTIAN JOURNAL OF BRONCHOLOGY}, year=2022}